| Y. HAN1, K. PENG1, Y. LIU1, X. LIU1, R. MA2, J. LI1, W.
ZHAO3, Q. ZHAO2, and H. LIU1 1Peking University School and Hospital
of Stomatology, Beijing, China, 2Contagious Hospital of Henan Province,
Beijing, China, 3College of Stomatology, Jiamusi University, Beijing, China
Objectives: To evaluate performance of a convenient assay
for anti-HIV antibody on saliva and gingival crevicular fluid (GCF) and to
compare its sensitivity with a standard serum HIV antibody Western Blot.
Method: 153 saliva samples and 177 GCF samples were
collected from patients who were serum HIV-positive detected on Western
Blot. The saliva was unstimulated whole saliva and GCF was collected by
inserting Whatman filter paper of 2×10mm2 into the mesio-buccal gingival
sulcus of the right upper first molar for 30 seconds. The diagnostic kits
used for antibody detection to human immunodeficiency virus type 1 and/or 2
and HIV-1 antigen (ELISA) were produced by BioMerieux. The result were read
by ELISA reader (450±5nm wavelength).
Result: 150/153 (98.0%) of saliva samples and 150/177
(84.7%) of GCF samples were positive. Sensitivities of saliva HIV antibodies
and GCF antibodies were 98.0% and 84.7% respectively. The concentration of
HIV-antibody in HIV-positive individuals was significantly higher than that
in AIDS patients (P<0.05). ). Dividing the patients into 4 groups according
to levels of HIV-antibodies demonstrated the percentage of patients
receiving HAART was associated with the increase of antibody concentration
both in GCF and saliva. The concentration of HIV-antibody in both GCF and
saliva had no correlation with CD4+ count.
Conclusion: The saliva and GCF had a high sensitivity for
detection of HIV antibody. The sample is easy to collect and is non
invasive, and may more easily accepted by individuals. HAART may promote
patients to produce more salivary HIV antibodies. |